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ABSTRACT In the last few decades, increasing understanding of the pathomecha-
nisms involved in chronic urticaria has highlighted the heterogeneity of different 
subtypes, and chronic urticaria is now classified as chronic spontaneous urticaria and 
inducible urticaria. Although many factors are thought to be involved in chronic ur-
ticaria, the etiology is yet to be clarified. The purpose of this study was to investigate 
etiological factors in patients with chronic urticaria.
Five hundred patients with chronic urticaria, 351 women and 149 men, were studied 
for etiological factors. The autologous serum skin test was performed on 197 patients. 
Provocation testing for physical urticaria was performed on 354 patients. Patients 
with acute urticaria were excluded from the study.  We determined at least one focus 
of infection that might be involved in the etiology of the disease in 18.8% of cases. 
Patients with infections were treated, and symptoms resolved after treatment in six 
cases (5.3%). Autologous serum skin tests were positive in 125 patients (63.5%). Prov-
ocation tests for physical urticaria were positive in 131 (37%) patients with urticaria. 
We suggest that physical stimuli and autoantibodies play an important role in the 
etiopathogenesis of urticaria.
KEY WORDS: urticaria, etiopathogenesis, physical urticaria, autologous se-
rum skin test 
INTRODUCTION
Chronic urticaria has been divided into two sub-
groups by the European Academy of Allergy and Clin-
ical Immunology (EAACI), Global Allergy and Asthma 
European Network (GA2LEN), European Dermatology 
Forum (EDF), and World Allergy Organization (WAO): 
chronic spontaneous urticaria and inducible urticaria 
(1,2). 
Any form of urticaria recurring two times a week 
for six weeks are classified as chronic urticaria (3,4). 
This form of the disease usually appears in adults be-
tween 20 and 45 years of age. Women are affected 
twice as frequently as men (5,6).
 Chronic urticaria accounts for 5-20% of all 
urticaria cases, and the cause is unknown in 70-90% 
(7,8). According to recent evidence, some 30% of 
chronic urticaria cases have been associated with 
autoimmunity, and approximately 20-50% of chronic 
urticaria cases are caused by physical agents. Most 
studies of chronic urticaria have shown that when the 
etiological agent is not identified at history and exam-
ination, it is almost impossible to identify it through 
other investigations (1,7). Our aim was therefore to 
determine etiological factors in patients presenting 
with chronic urticaria to our dermatology outpatient 
clinic.
STUDY PARTICIPANTS AND METHODS
The study included 500 patients presenting with 
chronic urticaria to Dermatology Outpatient Clinic 
of the Yozgat Bozoh University Medical Faculty and 
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Kajseri Training and Research Hospital between Oc-
tober 2010 and April 2014. Demographic features, 
types and duration of urticaria, medications used, 
accompanying diseases, and findings from physi-
cal examinations and laboratory investigations were 
recorded on patient follow-up forms. Patients with 
acute urticaria were not included in the study.  
At first presentation, patients were asked to com-
plete a brief questionnaire about possible causes of 
urticaria. They were then interviewed in detail about 
the items they marked. Patients were then examined. 
Complete blood count, erythrocyte-sedimentation 
rate, routine biochemical investigations, hepatitis 
markers, thyroid function tests, thyroid autoantibod-
ies (antimicrosomal and antithyroglobulin), complete 
urine analysis, and examination of parasites in faeces 
were requested. Complements and C1 esterase in-
hibitor levels in cases of urticaria accompanying an-
gioedema and immunoglobulin E (IgE) levels in cases 
of urticaria with a history of atopia were determined. 
The prick test was performed when necessary. Based 
on the results obtained, further investigations were 
performed and consultations with relevant medical 
disciplines were requested.
In order to identify and exclude physical urticarias 
(PUs) and autoimmune urticaria, antihistamine treat-
ment was withheld for at least three days in patients 
unlikely to be affected by this discontinuation, and 
appropriate provocation tests and autologous serum 
skin tests were carried out. No patients were using 
antihistaminics with an effect lasting for more than 
24 hours.  
For diagnosis of symptomatic dermographism, 
trauma to the back or the forearm was induced with 
a blunt-tipped device. One or three minutes later, 
trauma-related urticaria development was evaluated. 
To evaluate late pressure urticaria, pressure (3-4 kg) 
was applied to the forearm for five minutes. The re-
sulting erythematous plaques were examined after 
30 minutes and after eight hours. In order to evalu-
ate acquired cold urticaria, an ice cube was placed on 
the inner side of the forearm for 5-15 minutes, and 
the resulting urticaria was evaluated 5-15 minutes 
later. Anti-nuclear antibody (ANA), cryoglobulin, cold 
agglutinins, and cryofibrinogen were investigated in 
all patients with a history of acquired cold urticaria. 
In order to evaluate hot urticaria, a plastic tube con-
taining hot water at 40-50˚C was placed on the inner 
side of the forearm for five minutes, and the result-
ing lesion was evaluated for urticaria development 
5-10 minutes later. In order to evaluate solar urticaria, 
body parts were examined 1-3 minutes after exposure 
to artificial ultraviolet rays. For cholinergic urticaria 
evaluation, patients were asked to walk at a constant 
speed for 10-15 minutes until they perspired. Devel-
opment of urticaria was then investigated.
Autologous serum skin test (ASST) was adminis-
tered to 197 patients. An intradermal injection of 0.05 
ml serum derived from venous blood was performed 
to the inner side of the forearm. When erythema and 
edema appearing 30 minutes after the injection had 
a diameter at least 15 mm greater than that caused 
by injection of the control solution (NaCl), the test re-
sult was considered positive. 
RESULTS 
Of the 369 patients with chronic urticaria in this 
study, 259 were women and 110 men. The patients 
were aged 5-74 years, with a mean age of 37.15-
12.71 years. Duration of the disease ranged from six 
weeks to 33 years, with a mean of 3.87±5.13 years. 
Angioedema accompanied the disease in 228 cases 
(61.8%). 
Two hundred and fifteen patients (58.1%) had leu-
kocytosis. Of these, six (2.8%) had gastritis, five (1.4%) 
tooth decay, five (1.4%) urinary tract infection, three 
(0.8%) pelvic inflammatory disease, and three (0.8%) 
cholelithiasis. Out the 19 patients determined to 
have eosinophilia (5.1%), five (15.8%) had a history of 
atopia, two (10.5%) had increased IgE, seven (36.8%) 
had Blastocystis hominis in faeces, and two (10.5%) 
had Taenia saginata. Fifteen patients (4.1%), 10 (2.7%) 
women and five (1.4%) men, had anaemia. Of the 27 
patients determined to have increased sedimentation 
rates (7.3%), nine (33.3%) exhibited leukocytes and 
bacteria at urine analyses, four (14.8%) had anaemia, 
three (11.1%) had tooth decay, three (11.1%) sinus-
Table 1. Responses of infections detected in patients with chronic urticaria to treatment
Urticaria subsiding 








Yes 0 0 4 (%1.1%) 0 0 2 (0.5%)
No 26 (7.0%) 29 (7.8%) 68 (18.4%) 20 (5.4%) 2 (0.5%) 9 (2.5%)
Total 26 (7.0%) 29 (7.8%) 72 (19.5%) 20 (5.4%) 2 (0.5%) 11 (3.0%)
URTI: upper respiratory tract infection; PID: pelvic inflammatory disease
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itis, three (11.1%) hepatitis B infection, three (11.1%) 
internal malignity (thyroid lymphoma, breast carci-
noma), and two (7.4%) hepatitis C infection.
Leukocytes and bacteria were observed at urine 
analysis in 84 patients (22.7%). Escherichia coli was 
isolated in the urine culture of four patients. Urticaria 
did not resolve in the patients receiving treatment for 
urinary tract infection. B. hominis was determined in 
103 patients (27.8%) at laboratory investigations for 
parasites in faeces, and those patients with symp-
toms for the parasites were treated. In addition, four 
patients (1.1%) had Giardia intestinalis, six (1.6%) had 
Entamoeba histolytica, two (0.5%) had Entamoeba coli, 
and two (0.5%) had T. saginata. Urticaria subsided in 
two patients with giardiasis and two patients with 
amoeba after treatment for these parasites. Investi-
gations for other sources of infection revealed sinus-
itis in 29 patients (7.8%), hepatitis B positivity in 14 
(3.8%), hepatitis C positivity in six (1.6%), sore throat 
with hemolytic β streptococcus in two (0.5%), vagini-
tis in 10 female patients (2.7%), and pelvic inflamma-
tory disease in one female patient (0.3%). Treatment 
for infection led to an improvement in urticaria in 
only one female patient with vaginitis (Table 1).
Of the 39 patients with a history of atopia (10.5%), 
25 had IgE levels exceeding 100 mg/dl. Thirty-five pa-
tients were administered the prick test, and allergy 
to one or more substances was determined in 16 pa-
tients (4.3%). The most frequent allergens were Der-
matophagoides farinae, Dermatophagoides pteronyys-
sinus, tree pollens, and a mixture of crops and herb 
pollens. Three patients with positive prick test results 
had increased IgE.
One hundred and six patients (28.6%) had a his-
tory of medication directed towards treatment of hy-
pertension, diabetes, heart disease, hyperlipidemia, 
arthralgia, migraine, asthma, epilepsy, goitre, benign 
prostate hyperplasia, hormonal impairment, or con-
traception. Changing angiotensin converting enzyme 
(ACE) inhibitor as antihypertensive medication in two 
cases and withdrawal of aspirin in one case led to an 
an improvement in urticaria.
Twelve patients (2.3%) had antinuclear antibody 
(ANA) positivity. One patient with ANA positivity had 
solar urticaria. Another patient with ANA positivity 
was diagnosed with systemic lupus erythematosus.
Of the 228 patients with urticaria accompanied by 
angioedema, 17 (7.5%) had decreased C1 esterase in-
hibitor levels. Two (0.5%) were found to have heredi-
tary angioedema.
Thyroid function tests showed hypothyroiditis in 
13 patients (3.5%) and hyperthyroiditis in four (1.1%). 
Thirty-three patients (8.9%) had antimicrosomal posi-
tivity, 12 patients (3.2%) had antithyroglobulin anti-
body positivity, and 39 patients (10.5%) had positivity 
for both antibodies.
One hundred and five out of 150 patients with 
chronic urticaria underwent ASST (70%), and 20 out 
of 47 patients with PU (42.6%) had positive test re-
sults. Of the 125 patients with ASST positivity, 79 
were women and 46 men. The rate of ASST positivity 
was higher among female patients, though not sig-
nificantly so (P>0.05) (Table 2). Twenty-five patients 
had positivity for both ASST and at least one thyroid 
autoantibody (20%). However, there was no signifi-
cant relation between positivity for ASST and thyroid 
autoantibody positivity (P>0.05) (Table 3).
Of the 354 patients administered provocation 
tests, 131 (37.0%) had positivity for PU. Ninety-one of 
the patients with PU were women and 40 were men. 
Ages ranged between 5 and 74 years, with a mean age 
of 34.57 ±12.15 years. Duration of the disease ranged 
from 6 weeks to 30 years, with a mean duration of 
3.78 ±5.84 years. Forty-three patients with PU (32.8%) 
had accompanying angioedema. Of all the patients 
with PU, 104 (29.4%) had symptomatic dermogra-
phism, 10 (2.8%) had acquired cold urticaria, two 
(0.6%) had hot urticaria, one (0.3%) had solar urticar-
ia, four (1.1%) had symptomatic dermographism and 
late pressure urticaria, three (0.8%) had symptomatic 
dermographism and acquired cold urticaria, and one 
had symptomatic dermographism and aquagenic ur-
ticaria (0.3%). Thirteen (3.7%) of the 354 patients had 
cholinergic urticaria. Six patients with PU, four (1.1%) 
with symptomatic dermographism, and two (0.6%) 
with acquired cold urticaria had accompanying cho-
linergic urticaria (Table 4). Fifteen cases of acquired 
cold urticaria (4.2%) had a primary disease. Twenty 
ASST
Gender Negative Positive Total
Female 47 (37.3%) 79 (62.7%) 126 (100.0%)
Male 25 (35.2%) 46 (64.8%) 71 (100.0%)
P>0.05 72 (36.5%) 125 (63.5%) 197 (100.0%)
Table 3. A comparison of results of autologuous 
serum skin test (ASST) with rates of anti-TPO and/
or anti-TG antibody positivity
Anti-TPO and/or anti-TG
ASST Negative Positive Total
Positive 100 (%80.0) 25 (%20.0) 125 (%100.0)
Negative 13 (%18.1) 59 (%81.9) 72 (%100.0)
P>0.05 113 (%57.3) 84 (%42.6) 197 (%100.0)
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Table 2. Distribution of autologuous serum skin 
test (ASST) positivity by genders
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patients with positivity for ASST (16%) also exhibited 
PU positivity at provocation tests. Of these 20 pa-
tients, 12 (60%) had symptomatic dermographism, 
three (15%) had cold urticaria, two (10%) had cholin-
ergic urticaria, one (5%) had cholinergic urticaria and 
cold urticaria, one (5%) had symptomatic dermog-
raphism and aquagenic urticaria, and one (5%) had 
symptomatic dermographism and cold urticaria.
Three hundred and sixty-four patients (72.8%) 
reported one or more of the following items in the 
questionnaire concerning causes of urticaria: stress, 
an event strongly affecting the individual, nervous-
ness-restlessness-anxiety, sadness-unhappiness-pes- 
simism, sleep disorders, or a problem requiring pro-
fessional help. These patients were interviewed 
about the items they confirmed. Psychiatric consulta-
tions were requested for 105 patients (29%). Of these 
105, 60 (57.1%) were recommended medical treat-
ment. The most frequent diagnoses were depression 
(16.4%), generalized anxiety disorder (15.1%), and 
adaptation disorder (9.6%). 
Skin biopsy was performed in 14 cases (2.8%) in 
which urticaria could not be differentiated from ur-
ticarial vasculitis. Five (35.7%) had urticarial vascu-
litis and five (35.7%) had urticaria, but four (28.6%) 
exhibited no important features at histological 
examination.
DISCUSSION
Although clinically different subtypes of chronic 
urticaria have been described by the EAACI, GA2LEN, 
EDF and WAO, a patient may have two or more sub-
types of the disease. Although PUs exhibit the char-
acteristics of chronic urticaria, they fall under a differ-
ent category since their occurrence depends on the 
presence of physical factors. Since acute and chronic 
urticarias develop spontaneously without a specific 
outer stimulus, these are categorized as spontaneous 
urticaria (1,2,9).  
No specific triggering factors can be detected in 
approximately 75% cases of chronic urticaria (5). The 
causes of these urticarias are still unclear, and there 
are still problems with diagnostic investigation and 
treatment, which are mostly caused by PUs. PUs, ex-
cept for late pressure urticaria, do not last for more 
than two hours. However, lesions of chronic idio-
pathic urticaria (CIU) and chronic autoimmune urti-
caria (CAU) may persist for 4-36 hours (4). Since PUs 
are frequently accompanied by CIU, it is important to 
perform appropriate tests to diagnose them (9-11). 
It is also of particular importance to distinguish ur-
ticarial vasculitis from CIU. Absence of pigmentation 
after chronic urticaria lesions have healed is also im-
portant in terms of differential diagnosis (10).  
In agreement with the literature, most of the pa-
tients with chronic urticaria in this study were women 
(260 women compared to 110 men), and the mean 
duration of the disease was 3.6 ± 4.9 years (5,6).  
Although infections, metabolic and hormonal 
disorders, malignant diseases, and emotional factors 
have been incriminated in the etiology of chronic ur-
ticaria, there is no strong evidence for these (12,13). 
There have been many studies of comorbidity of 
chronic urticaria and chronic infections. However, 
there is no evidence that infectious pathogens lead 
to chronic urticaria (13,14). In this study, 29 patients 
(7.8%) had sinusitis, 26 (7%) had urinary infection, 
and two (0.5%) had upper respiratory tract infection 
caused by β haemolytic streptococci. Out of 11 fe-
male patients, 10 (2.7%) had vaginitis and one (0.3%) 
had pelvic inflammatory disease. Urticaria subsided 
in only two patients after treatment for vaginitis.



































































































Women 236 4 75 9 1 1 3 0 2 1 1
Men 118 9 29 1 1 0 1 1 1 1 3
Total 354 13 104 10 2 1 4 1 3 2 4
(%) 100.0 3.7 29.4 2.8 0.6 0.3 1.1 0.3 0.8 0.6 1.1
SD: symptomatic dermographism
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Parasitic infections may cause urticarial rash, 
especially in areas where parasitoses are endemic 
(4,10,14,15). In this study, 31.6% of subjects had para-
sites. Urticaria subsided in only four patients (1.1%) 
after treatment for parasitic infections. 
Although urticaria has been associated with hep-
atitis C infection, no significant increase has been ob-
served in the numbers of cases in which these two 
conditions are comorbid in large series (16). In the 
present study, 14 patients (3.8%) had hepatitis B and 
six (1.6%) had hepatitis C.
Apart from infections, non-infectious chronic in-
flammatory conditions are also implicated in the eti-
ology of chronic urticaria. These conditions include 
gastritis, reflux esophagitis, inflammation of the 
gallbladder and the bile ducts, and more rarely auto-
immune diseases such as systemic lupus erythema-
tosus and neoplasia (13,17). In the present study, 10 
patients (2.7%) had gastritis, three (0.8%) had reflux 
esophagitis, two (0.5%) had cholelithiasis, one (0.3%) 
had systemic lupus erythematosus, and six (1.6%) 
had internal malignity (one with brain tumour, one 
with thyroid lymphoma, one with colonic carcinoma, 
one with prostatic carcinoma, and two with breast 
carcinoma).
The incidence of atopia in patients with chronic 
urticaria is not as high as that in the general popula-
tion, and IgE levels are either normal or slightly high-
er than normal in most patients (18). In this study, 25 
out of 39 patients with a history of atopia (10.5%) had 
high levels of IgE. 
Although drugs are less frequently implicated in 
chronic urticaria, it is important to remember they 
may be causative factors (19). In one study, 9% of 
220 patients were found to have chronic urticaria 
due to medications and/or angioedema (20). In the 
present study, 28.6% of patients had a history of 
various medications. However, urticaria improved in 
only three cases after the suspect medication was 
withdrawn. Patients with chronic urticaria should be 
asked whether they take ACE inhibitors, aspirin, and 
non-steroidal anti-inflammatory drugs.
Comorbid chronic urticaria and angioedema have 
been reported in approximately 50% of cases (21). In 
the present study, chronic urticaria was accompanied 
by angioedema in 61.6% of patients. Angioedema 
developing due to hereditary deficiency of C1 ester-
ase inhibitors accounts for less than 0.1% of all cases 
of angioedema, and C4 levels are always low in these 
cases (22). In the present study, two patients (0.5%) 
had hereditary angioedema and low C4 levels, which 
is consistent with the literature (10,22).
Absence of any conditions likely to cause chronic 
urticaria in most cases suggests that it may be an au-
toimmune disease (23-25). This idea is also supported 
by the evidence that CIU is accompanied by autoim-
mune thyroiditis and, more specifically, the presence 
of IgG antibodies developing against thyroglobulin 
and peroxidise (4,12,26,27). Individuals with chronic 
urticaria have been shown to have higher serum 
concentrations of antithyroid antibodies than the 
normal population (24). The incidence of antithyroid 
antibodies in cases of chronic urticaria ranges from 
15% to 24% (4). Leznoff and Sussman (28) reported 
thyroid autoimmunity in 14.4% of 624 patients with 
chronic urticaria, compared to an incidence of 6% 
in the general population. In our study, 22.7% of pa-
tients exhibited positivity for one or more antithyroid 
autoantibodies, which is quite similar to the level re-
ported in the literature.
Recent studies have found IgG1 and IgG3, hista-
mine releasing circulating autoantibodies specific to 
the α subunit of the high affinity IgE receptor (FcεRI), 
in approximately 30%-60% of patients with chronic 
urticaria, and functional anti IgE antibodies at lower 
levels. These antibodies can in practice be detected 
using ASST, an inexpensive and reliable method. Sen-
sitivity and specificity of ASST have both been report-
ed at 80%. Apart from ASST positivity, various factors 
which lead to histamine release have been identified 
in patients with chronic autoimmune urticaria. When 
donor basophiles are incubated with patient serum, 
the serum of these patients may cause histamine 
release from the donor basophiles. ELISA and immu-
noblot techniques have helped to show autoantibod-
ies to FcεRI, not only in patients with chronic urticaria, 
but also in the normal population. These techniques 
do not seem to be sufficiently specific to detect func-
tional autoantibodies in chronic urticaria. The gold 
standard for detecting functional autoantibodies is 
therefore in vitro donor basophile histamine release. 
However, this is a lengthy procedure and difficult to 
perform. Since we could not perform this technique, 
we used ASST and determined positivity in 63.5% of 
patients, similar to the level reported in the literature 
(22,29-31). 
In recent years, higher rates of antimicrosomal an-
tibody positivity and abnormal thyroid function tests 
in patients with autoantibodies triggering histamine 
release have attracted the attention of researchers. Al-
though the incidence of thyroid autoimmune disease 
in CIU does not differ from that of the general popu-
lation, it should be noted that thyroid autoantibod-
ies may aggregate in patients with ASST positivity, 
in that they indicate antibodies triggering histamine 
release (32,33). We therefore investigated whether 
ASST results were associated with antithyroid anti-
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body positivity in patients with chronic urticaria. Out 
of 125 patients with ASST positivity, 25 (20%) exhib-
ited positivity for at least one thyroid autoantibody, 
although this was statistically insignificant (P>0.05).
PU is responsible for 20-31% of all cases of urti-
caria. According to more recent studies, this rate has 
increased to 71-80% (6,8,12,22). In the current study, 
37% of patients had PU. The most frequent type of PU 
was symptomatic dermographism, at 29.4%. These 
figures are consistent with the literature. It has been 
reported that only 5% of patients with cold urticaria 
may have secondary acquired cold urticaria (22). 
None of the patients in this study had secondary ac-
quired cold urticaria. Solar urticaria is a rare clinical 
picture and may coexist with systemic lupus erythe-
matosus and erythropoietic protoporphyria (6,12). 
Only one patient in this study, with no pathological 
conditions except for ANA positivity, was found to 
have solar urticaria.
ASST positivity accompanied by PUs in 16% of the 
patients in this study indicates that PUs may coexist 
with autoimmune urticaria.
Psychological factors may also be involved in 
cases of chronic urticaria. Some of the conditions di-
agnosed as CIU may be due to psychogenic factors. 
In fact, it is impossible to clearly define psychogenic 
urticaria. Many chronic diseases can be aggravated 
by emotional stress. It may be beneficial to provide 
psychiatric support for patients with suspected CIU 
and considerable emotional stress (6,12). Jáuregui et 
al. reported that chronic urticaria has an adverse im-
pact on quality of life (34). In this study, of the 364 pa-
tients with chronic urticaria reporting feeling stressed 
(72.8%), 105 (29%) were examined by a psychiatrist 
and 60 (16.5%) were recommended psychiatric 
treatment. 
CONCLUSION
In general, cases of urticaria or angioedema have 
clinical pictures which are not difficult to recognize 
with detailed history and examination. The problem 
is that determining the causes of urticaria and find-
ing the appropriate treatment in all conditions can 
be difficult. Therefore, appropriate diagnostic tests 
should be conducted to detect PUs and chronic au-
toimmune urticaria. An autoimmune mechanism and 
physical stimuli play an important part in the devel-
opment of urticarias.
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